肺貼片市場規模、佔有率和成長分析：按產品類型、應用、材料、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球肺貼片市場價值為 2.589 億美元，預計到 2033 年將從 2025 年的 2.778 億美元成長至 4.8813 億美元，預測期（2026-2033 年）的複合年成長率為 7.3%。

全球肺補片市場在再生醫學領域正迅速發展，其主要驅動力是慢性呼吸系統疾病（如慢性阻塞性肺病(COPD) 和特發性肺纖維化）的日益普遍，這些疾病的患者群體大規模。傳統療法通常依賴藥物治療或肺移植，但這些療法面臨低存活率、供體短缺等挑戰，因此，創新組織補片正成為市場發展的驅動力。在這個市場中，製造技術和醫療技術的整合發揮著至關重要的作用，透過積層製造技術開發出能夠模擬肺泡結構的補片，降低了排斥反應的發生率，並加快了核准流程。此外，支氣管鏡等微創給藥方式的出現，也使得補片的應用範圍更加廣泛，例如，可以利用藥物緩釋塗層來應對發炎和組織阻塞等挑戰。

全球肺補片市場的成長要素

全球肺部貼片市場正受到可拉伸聚合物技術進步的顯著推動。這項技術能夠改善貼片與肺組織的貼合度，減少刺激，並提升整體療效。醫生可以從這些創新材料的應用中獲益，例如延長貼片的使用時間，並簡化術後護理流程。這些創新有助於產品差異化，提高醫生的接受度，並擴大其在各種慢性呼吸系統疾病中的應用範圍。這些積極成果不僅改善了患者體驗，還提高了患者的依從性，最終促進了市場的永續成長，並推動了呼吸健康解決方案領域的發展。

全球肺貼片市場的限制因素

肺貼片的生產涉及將生物活性材料封裝在複雜的聚合物基質中的複雜工藝，需要專用設備和熟練人員，這帶來了巨大的挑戰。這種複雜性導致生產前置作業時間長，更容易出現品管問題，使得製造商難以擴大生產規模。因此，市場供應有限，採購耗時，中小企業難以進入該行業。最終，這種情況阻礙了全球肺貼片市場的整體成長和擴張潛力。

全球肺貼片市場趨勢

受生物材料和細胞工程技術進步的推動，全球肺補片市場正經歷著向個人化再生醫學的重大轉變。客製化肺部補片的出現，能夠滿足患者獨特的解剖和病理需求，反映了個人化醫療解決方案日益成長的趨勢。 3D列印、生物墨水和患者自身細胞等創新技術正在改進這些植入的製造程序，最大限度地降低併發症風險，並促進康復。這與人們日益成長的以價值為導向的醫療理念相契合，也對尋求有效、以患者為中心、能夠改善整體治療效果的支付方極具吸引力。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球肺貼片市場規模：依產品類型分類

• 生物來源貼片
• 合成貼片
• 複合補丁
• 其他

全球肺貼片市場規模：按應用領域分類

• 肺組織修復
• 空氣洩漏管理
• 胸腔外科
• 創傷修復
• 其他

全球肺補片市場規模：依材料分類

• 膠原蛋白
• ePTFE
• 聚氨酯
• 其他

全球肺貼片市場規模：依最終用戶分類

• 醫院
• 胸腔科醫療中心
• 門診手術中心
• 其他

全球肺貼片市場規模：依通路分類

• 直銷
• 醫療設備銷售代理
• 其他

全球肺貼片市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Baxter International Inc.
• WL Gore & Associates, Inc.
• LeMaitre Vascular, Inc.
• Edwards Lifesciences Corporation
• Terumo Corporation
• Artivion, Inc.
• Getinge AB
• B. Braun SE
• BioTissue Holdings Inc.
• Synovis Micro Companies Alliance, Inc.
• Cook Medical LLC
• Integra LifeSciences Holdings Corporation
• CorMatrix Cardiovascular, Inc.
• Xeltis BV
• Admedus Ltd.
• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Aziyo Biologics, Inc.
• CollPlant Biotechnologies Ltd.

結論與建議

Global Pulmonary Patch Market size was valued at USD 258.9 Million in 2024 and is poised to grow from USD 277.8 Million in 2025 to USD 488.13 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global pulmonary patch market is rapidly advancing within the realm of regenerative medicine, driven by the rising prevalence of chronic respiratory disorders such as COPD and idiopathic pulmonary fibrosis, creating a significant patient base. Traditional treatment methods, often reliant on medications or lung transplants, have faced challenges due to low survival rates and donor shortages, prompting a shift towards innovative tissue patches. The integration of manufacturing and medical technology plays a crucial role in this market, enabling the development of patches that mimic the alveolar structure through additive manufacturing. This has led to lower rejection rates and expedited approvals. Additionally, the move towards minimally invasive delivery methods, such as bronchoscopy, facilitates broader applications, including potential drug-eluting coatings to address inflammation and tissue closure challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pulmonary Patch market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pulmonary Patch Market Segments Analysis

Global pulmonary patch market is segmented by product type, application, material, end user, distribution channel and region. Based on product type, the market is segmented into Biological Patches, Synthetic Patches, Composite Patches and Others. Based on application, the market is segmented into Lung Tissue Repair, Air Leak Management, Thoracic Surgery, Trauma Repair and Others. Based on material, the market is segmented into Collagen, ePTFE, Polyurethane and Others. Based on end user, the market is segmented into Hospitals, Specialty Thoracic Centers, Ambulatory Surgical Centers and Others. Based on distribution channel, the market is segmented into Direct Sales, Medical Device Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pulmonary Patch Market

The global Pulmonary Patch market is significantly driven by advancements in stretchable polymers that enhance patch compatibility with lung tissues, reducing irritation and boosting overall effectiveness. As physicians adopt these innovative materials, they benefit from extended wear times and streamlined post-operative procedures. Such innovations promote product differentiation, leading to increased physician acceptance and the potential for broader applications across various chronic respiratory conditions. This positive outcome not only enhances patient experiences but also improves patient compliance, which ultimately contributes to sustained market growth, fostering a developing landscape in respiratory health solutions.

Restraints in the Global Pulmonary Patch Market

The production of pulmonary patches presents significant challenges due to the intricate process of depositing bioactive materials within elaborate polymer matrices, necessitating specialized equipment and skilled personnel. This complexity leads to extended production timelines and a higher incidence of quality control failures, complicating the scaling of operations for manufacturers. Consequently, these factors contribute to a limited supply in the market, resulting in prolonged procurement durations and a lack of motivation for smaller companies to enter the industry. This situation ultimately stifles the overall growth and expansion potential of the global pulmonary patch market.

Market Trends of the Global Pulmonary Patch Market

The Global Pulmonary Patch market is experiencing a significant shift towards personalized regenerative therapies, fueled by advancements in biomaterials and cellular engineering. The emergence of custom-tailored pulmonary patches that cater to the unique anatomical and pathological needs of patients reflects a growing trend in individualized medical solutions. Innovations such as 3D printing, bio-inks, and the utilization of patient-derived cells are enhancing the production of these implants, minimizing the risk of complications and expediting rehabilitation. This aligns with the increasing preference for value-based healthcare, appealing to payers seeking effective, patient-specific treatment options that enhance overall outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pulmonary Patch Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Biological Patches
• Synthetic Patches
• Composite Patches
• Others

Global Pulmonary Patch Market Size by Application & CAGR (2026-2033)

• Market Overview
• Lung Tissue Repair
• Air Leak Management
• Thoracic Surgery
• Trauma Repair
• Others

Global Pulmonary Patch Market Size by Material & CAGR (2026-2033)

• Market Overview
• Collagen
• ePTFE
• Polyurethane
• Others

Global Pulmonary Patch Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Thoracic Centers
• Ambulatory Surgical Centers
• Others

Global Pulmonary Patch Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Device Distributors
• Others

Global Pulmonary Patch Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Material, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Material, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Material, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Material, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Material, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synovis Micro Companies Alliance, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorMatrix Cardiovascular, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xeltis B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Admedus Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CollPlant Biotechnologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations